|
SPRY1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.139999998376E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.45460000045006E-07 |
| Normal-vs-Stage2 |
7.509500E-02 |
| Normal-vs-Stage3 |
2.543200E-01 |
| Normal-vs-Stage4 |
3.320400E-02 |
| Stage1-vs-Stage2 |
4.819800E-01 |
| Stage1-vs-Stage3 |
5.865600E-02 |
| Stage1-vs-Stage4 |
4.014000E-01 |
| Stage2-vs-Stage3 |
5.148400E-01 |
| Stage2-vs-Stage4 |
8.297600E-01 |
| Stage3-vs-Stage4 |
7.173400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.03909999996199E-08 |
| Normal-vs-AfricanAmerican |
6.098100E-02 |
| Normal-vs-Asian |
7.73010000010288E-07 |
| Caucasian-vs-AfricanAmerican |
9.475700E-02 |
| Caucasian-vs-Asian |
4.638600E-01 |
| AfricanAmerican-vs-Asian |
5.484100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62525548574877E-12 |
| Normal-vs-Female |
2.446200E-01 |
| Male-vs-Female |
9.224400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.636270E-03 |
| Normal-vs-Extreme_Weight |
5.09337017007283E-12 |
| Normal-vs-Obese |
7.063100E-03 |
| Normal-vs-Extreme_Obese |
2.60091947978935E-12 |
| Normal_Weight-vs-Extreme_Weight |
6.696000E-02 |
| Normal_Weight-vs-Obese |
7.950600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.202100E-04 |
| Extreme_Weight-vs-Obese |
4.191700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.151900E-04 |
| Obese-vs-Extreme_Obese |
5.431500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.488600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.60499999957153E-07 |
| Normal-vs-Age(61-80Yrs) |
3.60559999634802E-08 |
| Normal-vs-Age(81-100Yrs) |
4.68169999989776E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.980220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.484020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.810400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.674400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.949800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.901350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.99451566373909E-12 |
| Normal-VS-Type2 PRCC |
4.24890000000344E-05 |
| Normal-VS-KIRP CIMP |
2.044600E-01 |
| Normal-VS-Unclassified PRCC |
6.32829999513973E-09 |
| Type1 PRCC-VS-Type2 PRCC |
9.001200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.867960E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.619800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.331800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.849900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.284200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.29130048268189E-10 |
| Normal-vs-N1 |
5.545200E-01 |
| Normal-vs-N2 |
7.046400E-01 |
| N0-vs-N1 |
2.778200E-02 |
| N0-vs-N2 |
1.040380E-01 |
| N1-vs-N2 |
6.853200E-01 |
|
|
